Gateway Gastroenterology, is a leader in healthcare management, now offers FibroScan® to assess liver health and support early detection and management of liver disease. Liver disease, such as nonalcoholic fatty liver disease (NAFLD), is associated with obesity, insulin resistance, diabetes and other metabolic risk factors. One in three Americans have liver disease.1
Maintaining good liver health is important to your overall health. That’s why physicians at Gateway Gastroenterology use FDA-approved FibroScan®:
FibroScan: How it works
1 Caminiti, Susan; More than 80 million Americans have this deadly disease, and many don’t even know it’ CNBC; Nov. 1,
2017; https://www.cnbc.com/2017/10/31/fatty-liver-disease-affects-80-million-americans.html; accessed July 23, 2020.